Patent · US Active

Method for determining the total clotting activity of a blood or plasma sample

US8163513B2 · kind B2 · utility

0Cited by

4References

6Claims

0Family size

Assignee

JenAffin GmbH · DE

Inventors

Gotz Nowak · Erfurt, DE
Elke Bucha · Erfurt, DE
Ute Lange · Kahla, DE

Key dates

Filing date	Feb 17, 2006
Grant date	Apr 24, 2012
Priority date	—
Expiry date	Apr 22, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/974
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to a method for determining the total clotting activity of a blood or plasma sample, characterized in that a highly specific, reversible thrombin inhibitor is added to a blood or plasma sample in a defined amount, the clotting of the blood or plasma sample is induced and, after a defined period of time, the consumed amount of the added thrombin inhibitor is determined in a per se known manner, as well as to a kit for obtaining information about the state of coagulation of a blood sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.